Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis
Clinical trial NCT02245360 · COMPLETED
Trial details
- NCT number
- NCT02245360
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-03-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.